NeoGenomics, Inc. (NEO)

NeoGenomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,285	2,115	2,062	1,167	4,201	5,978
Market Cap Growth	2.57%	2.57%	76.72%	-72.22%	-29.73%	95.74%
Enterprise Value	1,504	2,334	2,266	1,335	4,271	5,914
Last Close Price	10.09	16.48	16.18	9.24	34.12	53.84
PE Ratio	-	-	-	-	-	1432.85
Forward PE	59.35	103.91	-	-	-	198.16
PS Ratio	1.93	3.20	3.49	2.29	8.67	13.45
PB Ratio	1.43	2.34	2.19	1.17	3.79	8.61
P/TBV Ratio	32.22	53.03	45.19	17.42	30.26	16.49
P/OCF Ratio	183.01	301.21	-	-	-	4094.41
PEG Ratio	-	-	-	-	-	20.89
EV/Sales Ratio	2.28	3.53	3.83	2.62	8.82	13.31
EV/EBITDA Ratio	1764.99	2739.25	-	-	-	272.15
Debt / Equity Ratio	0.67	0.67	0.65	0.61	0.55	0.32
Debt / EBITDA Ratio	48.11	48.11	-	-	-	7.28
Asset Turnover	0.40	0.40	0.35	0.28	0.34	0.52
Inventory Turnover	14.56	14.56	14.33	13.50	11.23	11.77
Quick Ratio	1.78	1.78	5.67	6.22	7.21	5.53
Current Ratio	1.98	1.98	6.20	6.73	7.81	6.13
Return on Equity (ROE)	-8.54%	-8.54%	-9.07%	-13.70%	-0.93%	0.69%
Return on Assets (ROA)	-2.70%	-2.70%	-3.49%	-5.30%	-5.19%	-1.03%
Return on Capital (ROIC)	-2.93%	-2.93%	-3.78%	-5.75%	-5.63%	-1.12%
Earnings Yield	-6.13%	-3.72%	-4.26%	-12.36%	-0.20%	0.07%
FCF Yield	-2.65%	-1.61%	-1.49%	-8.30%	-2.16%	-0.46%
Buyback Yield / Dilution	-0.92%	-0.92%	-1.03%	-3.55%	-7.31%	-7.89%

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q